loadpatents
name:-0.021788835525513
name:-0.0085411071777344
name:-0.0062501430511475
Instituto Carlos Slim de la Salud, A.C. Patent Filings

Instituto Carlos Slim de la Salud, A.C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Instituto Carlos Slim de la Salud, A.C..The latest application filed is for "compositions and methods related to di-substituted bicyclo[2.2.1] heptanamine-containing compounds".

Company Profile
4.8.14
  • Instituto Carlos Slim de la Salud, A.C. - Mexico City MX US
  • INSTITUTO CARLOS SLIM DE LA SALUD, A.C. - Colonia Granada Ampliacion, C.P. MX
  • INSTITUTO CARLOS SLIM DE LA SALUD, A.C. - Mexico, D.F., Mexico MX
  • Instituto Carlos Slim de la Salud, A.C. - Mexico MX
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compositions And Methods Related To Di-substituted Bicyclo[2.2.1] Heptanamine-containing Compounds
App 20220242815 - Chamberlain; Brian T. ;   et al.
2022-08-04
Therapeutic Treatment Of Microsatellite Unstable Cancers
App 20220133693 - Vazquez; Francisca ;   et al.
2022-05-05
Targeting Egln1 In Cancer
App 20220090083 - Hahn; William ;   et al.
2022-03-24
Tepoxalin Targeting Of Abcb1 Overexpressing Cancers
App 20220065864 - CORSELLO; Steven ;   et al.
2022-03-03
Agents For Reversing Toxic Proteinopathies
App 20220054433 - Greka; Anna ;   et al.
2022-02-24
Agents For Reversing Toxic Proteinopathies
App 20220023233 - Greka; Anna ;   et al.
2022-01-27
Aryl Hydrocarbon Receptor (ahr) Activator Compounds As Cancer Therapeutics
App 20220017524 - CORSELLO; Steven ;   et al.
2022-01-20
Vanadium Compositions And Methods For Treatment Of Cancer
App 20220008457 - CORSELLO; Steven ;   et al.
2022-01-13
Use Of Disulfiram And Other Compounds To Treat Cancers With Loss Of Chromosome 16q And/or Low Expression Of Metallothionein Proteins
App 20220010383 - CORSELLO; Steven ;   et al.
2022-01-13
Agents for reversing toxic proteinopathies
Grant 11,207,278 - Greka , et al. December 28, 2
2021-12-28
Agents For Reversing Toxic Proteinopathies
App 20210169827 - Greka; Anna ;   et al.
2021-06-10
Compounds And Methods For Regulating Insulin Secretion
App 20200017485 - BURNS; Sean M. ;   et al.
2020-01-16
Compositions And Methods For Detecting And Treating Diabetes
App 20190350938 - HOCH; EITAN ;   et al.
2019-11-21
Propeptide-luciferase fusion proteins and methods of use thereof
Grant 10,370,697 - Burns , et al.
2019-08-06
Methods of diagnosing and treating medullary cystic kidney disease
Grant 10,370,716 - Kirby , et al.
2019-08-06
Propeptide-luciferase Fusion Proteins And Methods Of Use Thereof
App 20170260565 - BURNS; SEAN ;   et al.
2017-09-14
Propeptide-luciferase fusion proteins and methods of use thereof
Grant 9,657,329 - Burns , et al. May 23, 2
2017-05-23
Compositions and methods of treating head and neck cancer
Grant 9,370,551 - Cong , et al. June 21, 2
2016-06-21
Methods Of Diagnosing And Treating Medullary Cystic Kidney Disease
App 20150252423 - KIRBY; Andrew ;   et al.
2015-09-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed